You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥師幫(9885.HK)獲評新財富“醫療產業最具成長性港股公司”
格隆匯 02-20 08:27

近日,在新財富雜誌2024年度評選中,醫藥互聯網標杆企業藥師幫(9885.HK)榮獲“醫療產業最具成長性港股公司”獎項。該獎項依據營收和淨利潤增速等指標,在消費、醫療等五大產業分別選出10家優秀企業,以此推動企業與投資者聚焦創新。公開數據顯示,藥師幫營收、淨利潤等各項關鍵指標持續向好,其以獨特的商業模式和強勁的發展在醫療行業中脫穎而出。近日,藥師幫發佈2024年正面盈利預告,預計2024年全年公司擁有人應佔利潤不低於人民幣2,000萬元,與上年同期的公司擁有人應佔虧損人民幣31.89億元相比,已實現由虧轉盈的跨越。此次藥師幫獲評爲新財富雜誌 “醫療產業最具成長性港股公司”,可視作市場的普遍認可。隨着院外醫藥行業數字化轉型和基層醫療需求的持續釋放,藥師幫有望憑藉自身優勢,持續打開增長空間,並引領行業朝着智能化、數字化方向加速變革,值得關注與期待。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account